Abstract
Purpose
Obstructive sleep apnea (OSA) patients are at increased risk for cardiovascular disease, stroke, atherosclerosis, hypertension, and venous thromboembolism. Elevated soluble P-selectin (sP-selectin) levels are also associated with increased risk of above diseases. But whether sP-selectin levels in OSA patients are higher than their counterparts remain unclear, since previous studies yielded inconsistent results. Therefore, a meta-analysis is warranted.
Methods
PubMed, Embase, Cochrane Library, and Web of Science databases were searched for eligible studies. Studies were included if they reported sP-selectin levels of both OSA patients and non-OSA controls. Standardized mean differences (SMDs) with 95% confidence intervals (CIs) were calculated to determine the effect sizes.
Results
Nine eligible studies were finally evaluated. When all the studies were pooled, sP-selectin levels in OSA patients were significantly higher than that in controls (SMD = 0.54, 95% CI 0.29–0.78, I2 = 66%, p < 0.0001). In the subgroup analysis based on BMI matched groups, sP-selectin levels were significantly higher in OSA patients than that in controls (SMD = 0.52, 95% CI 0.27–0.76, I2 = 23%, p < 0.0001). In the subgroup analysis stratified by blood source, either serum sP-selectin levels or plasma sP-selectin levels in OSA patients were higher than that in controls. Moderate-to-severe OSA patients had significant higher sP-selectin levels (SMD = 0.80, 95% CI 0.45–1.15, I2 = 67%, p < 0.00001), while mild OSA patients showed no significant difference with controls.
Conclusion
The pooled results reveal that OSA patients have higher sP-selectin levels than non-OSA controls. This conclusion remains unaltered in all subgroups other than the subgroup of mild OSA patients. Additional studies are warranted to better identify the role of sP-selectin as a potential biomarker in OSA patients.
Similar content being viewed by others
References
Devulapally K, Pongonis R Jr, Khayat R (2009) OSA: the new cardiovascular disease: part II: overview of cardiovascular diseases associated with obstructive sleep apnea. Heart Fail Rev 14(3):155–164. https://doi.org/10.1007/s10741-008-9101-2
Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V (2005) Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353(19):2034–2041. https://doi.org/10.1056/NEJMoa043104
Drager LF, Polotsky VY, Lorenzi-Filho G (2011) Obstructive sleep apnea: an emerging risk factor for atherosclerosis. Chest 140(2):534–542. https://doi.org/10.1378/chest.10-2223
Lippi G, Mattiuzzi C, Franchini M (2015) Sleep apnea and venous thromboembolism. A systematic review. Thromb Haemost 114(5):958–963. https://doi.org/10.1160/th15-03-0188
Geiser T, Buck F, Meyer BJ, Bassetti C, Haeberli A, Gugger M (2002) In vivo platelet activation is increased during sleep in patients with obstructive sleep apnea syndrome. Respiration 69(3):229–234. https://doi.org/10.1159/000063625
Salman LA, Shulman R, Cohen JB (2020) Obstructive sleep apnea, hypertension, and cardiovascular risk: epidemiology, pathophysiology, and management. Curr Cardiol Rep 22(2):6. https://doi.org/10.1007/s11886-020-1257-y
Liak C, Fitzpatrick M (2011) Coagulability in obstructive sleep apnea. Can Respir J 18(6):338–348. https://doi.org/10.1155/2011/924629
von Känel R, Dimsdale JE (2003) Hemostatic alterations in patients with obstructive sleep apnea and the implications for cardiovascular disease. Chest 124(5):1956–1967. https://doi.org/10.1378/chest.124.5.1956
André P, Hartwell D, Hrachovinová I, Saffaripour S, Wagner DD (2000) Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci USA 97(25):13835–13840. https://doi.org/10.1073/pnas.250475997
Kameda H, Morita I, Handa M, Kaburaki J, Yoshida T, Mimori T, Murota S, Ikeda Y (1997) Re-expression of functional P-selectin molecules on the endothelial cell surface by repeated stimulation with thrombin. Br J Haematol 97(2):348–355. https://doi.org/10.1046/j.1365-2141.1997.522700.x
Closse C, Seigneur M, Renard M, Pruvost A, Dumain P, Belloc F, Boisseau MR (1996) Influence of hypoxia and hypoxia-reoxygenation on endothelial P-selectin expression. Haemostasis 26(Suppl 4):177–181. https://doi.org/10.1159/000217296
Sun WY, Abeynaike LD, Escarbe S, Smith CD, Pitson SM, Hickey MJ, Bonder CS (2012) Rapid histamine-induced neutrophil recruitment is sphingosine kinase-1 dependent. Am J Pathol 180(4):1740–1750. https://doi.org/10.1016/j.ajpath.2011.12.024
Dong ZM, Brown AA, Wagner DD (2000) Prominent role of P-selectin in the development of advanced atherosclerosis in ApoE-deficient mice. Circulation 101(19):2290–2295. https://doi.org/10.1161/01.cir.101.19.2290
Ridker PM, Buring JE, Rifai N (2001) Soluble P-selectin and the risk of future cardiovascular events. Circulation 103(4):491–495. https://doi.org/10.1161/01.cir.103.4.491
Horváth P, Lázár Z, Gálffy G, Puskás R, Kunos L, Losonczy G, Mészáros M, Tárnoki ÁD, Tárnoki DL, Bikov A (2020) Circulating P-selectin glycoprotein ligand 1 and P-selectin levels in obstructive sleep apnea patients. Lung 198(1):173–179. https://doi.org/10.1007/s00408-019-00299-0
Celi A, Pellegrini G, Lorenzet R, De Blasi A, Ready N, Furie BC, Furie B (1994) P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci USA 91(19):8767–8771. https://doi.org/10.1073/pnas.91.19.8767
Polgar J, Matuskova J, Wagner DD (2005) The P-selectin, tissue factor, coagulation triad. J Thromb Haemost 3(8):1590–1596. https://doi.org/10.1111/j.1538-7836.2005.01373.x
del Conde I, Nabi F, Tonda R, Thiagarajan P, López JA, Kleiman NS (2005) Effect of P-selectin on phosphatidylserine exposure and surface-dependent thrombin generation on monocytes. Arterioscler Thromb Vasc Biol 25(5):1065–1070. https://doi.org/10.1161/01.ATV.0000159094.17235.9b
Blann AD, Nadar SK, Lip GY (2003) The adhesion molecule P-selectin and cardiovascular disease. Eur Heart J 24(24):2166–2179. https://doi.org/10.1016/j.ehj.2003.08.021
O’Brien LM, Serpero LD, Tauman R, Gozal D (2006) Plasma adhesion molecules in children with sleep-disordered breathing. Chest 129(4):947–953. https://doi.org/10.1378/chest.129.4.947
Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097. https://doi.org/10.1371/journal.pmed.1000097
Luo D, Wan X, Liu J, Tong T (2018) Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res 27(6):1785–1805. https://doi.org/10.1177/0962280216669183
Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 14:135. https://doi.org/10.1186/1471-2288-14-135
Chang YT, Lin HC, Chang WN, Tsai NW, Huang CC, Wang HC, Kung CT, Su YJ, Lin WC, Cheng BC, Su CM, Chen TY, Chiang YF, Lu CH (2017) Impact of inflammation and oxidative stress on carotid intima-media thickness in obstructive sleep apnea patients without metabolic syndrome. J Sleep Res 26(2):151–158. https://doi.org/10.1111/jsr.12477
Cofta S, Wysocka E, Dziegielewska-Gesiak S, Michalak S, Piorunek T, Batura-Gabryel H, Torlinski L (2013) Plasma selectins in patients with obstructive sleep apnea. Adv Exp Med Biol 756:113–119. https://doi.org/10.1007/978-94-007-4549-0_15
Minoguchi K, Yokoe T, Tazaki T, Minoguchi H, Oda N, Tanaka A, Yamamoto M, Ohta S, O’Donnell CP, Adachi M (2007) Silent brain infarction and platelet activation in obstructive sleep apnea. Am J Respir Crit Care Med 175(6):612–617. https://doi.org/10.1164/rccm.200608-1141OC
Niżankowska-Jędrzejczyk A, Almeida FR, Lowe AA, Kania A, Nastałek P, Mejza F, Foley JH, Niżankowska-Mogilnicka E, Undas A (2014) Modulation of inflammatory and hemostatic markers in obstructive sleep apnea patients treated with mandibular advancement splints: a parallel, controlled trial. JCSM 10(3):255–262. https://doi.org/10.5664/jcsm.3522
Bravo Mde L, Serpero LD, Barceló A, Barbé F, Agustí A, Gozal D (2007) Inflammatory proteins in patients with obstructive sleep apnea with and without daytime sleepiness. Sleep Breath 11(3):177–185. https://doi.org/10.1007/s11325-007-0100-7
Dyugovskaya L, Polyakov A, Lavie P, Lavie L (2008) Delayed neutrophil apoptosis in patients with sleep apnea. Am J Respir Crit Care Med 177(5):544–554. https://doi.org/10.1164/rccm.200705-675OC
García Suquia A, Alonso-Fernández A, de la Peña M, Romero D, Piérola J, Carrera M, Barceló A, Soriano JB, Arque M, Fernández-Capitán C, Lorenzo A, García-Río F (2015) High D-dimer levels after stopping anticoagulants in pulmonary embolism with sleep apnoea. Eur Respir J 46(6):1691–1700. https://doi.org/10.1183/13993003.02041-2014
Winiarska HM, Cofta S, Bielawska L, Płóciniczak A, Piorunek T, Wysocka E (2020) Circulating P-selectin and its glycoprotein ligand in nondiabetic obstructive sleep apnea patients. Adv Exp Med Biol 1279:61–69. https://doi.org/10.1007/5584_2020_501
Robinson GV, Pepperell JC, Segal HC, Davies RJ, Stradling JR (2004) Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax 59(9):777–782. https://doi.org/10.1136/thx.2003.018739
Phillips BG, Kato M, Narkiewicz K, Choe I, Somers VK (2000) Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol 279(1):H234-237. https://doi.org/10.1152/ajpheart.2000.279.1.H234
Corsonello A, Malara A, Ientile R, Corica F (2002) Leptin enhances adenosine diphosphate-induced platelet aggregation in healthy subjects. Obes Res 10(4):306. https://doi.org/10.1038/oby.2002.42
Nadeem R, Molnar J, Madbouly EM, Nida M, Aggarwal S, Sajid H, Naseem J, Loomba R (2013) Serum inflammatory markers in obstructive sleep apnea: a meta-analysis. JCSM 9(10):1003–1012. https://doi.org/10.5664/jcsm.3070
De Pergola G, Pannacciulli N, Coviello M, Scarangella A, Di Roma P, Caringella M, Venneri MT, Quaranta M, Giorgino R (2008) sP-selectin plasma levels in obesity: association with insulin resistance and related metabolic and prothrombotic factors. Nutr Metab Cardiovasc Dis 18(3):227–232. https://doi.org/10.1016/j.numecd.2006.09.010
Ziccardi P, Nappo F, Giugliano G, Esposito K, Marfella R, Cioffi M, D’Andrea F, Molinari AM, Giugliano D (2002) Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 105(7):804–809. https://doi.org/10.1161/hc0702.104279
Peng M, Chen R, Cheng J, Li J, Liu W, Hong C (2018) Application value of the NoSAS score for screening sleep-disordered breathing. J Thorac Dis 10(8):4774–4781. https://doi.org/10.21037/jtd.2018.07.46
Harsch IA, Wallaschofski H, Koebnick C, Pour Schahin S, Hahn EG, Ficker JH, Lohmann T (2004) Adiponectin in patients with obstructive sleep apnea syndrome: course and physiological relevance. Respiration 71(6):580–586. https://doi.org/10.1159/000081758
Csongrádi É, Káplár M, Nagy B Jr, Koch CA, Juhász A, Bajnok L, Varga Z, Seres I, Karányi Z, Magyar MT, Oláh L, Facskó A, Kappelmayer J, Paragh G (2017) Adipokines as atherothrombotic risk factors in obese subjects: Associations with haemostatic markers and common carotid wall thickness. Nutr Metab Cardiovasc Dis 27(6):571–580. https://doi.org/10.1016/j.numecd.2017.02.007
Seravalle G, Mancia G, Grassi G (2018) Sympathetic nervous system, sleep, and hypertension. Curr Hypertens Rep 20(9):74. https://doi.org/10.1007/s11906-018-0874-y
Abboud F, Kumar R (2014) Obstructive sleep apnea and insight into mechanisms of sympathetic overactivity. J Clin Investig 124(4):1454–1457. https://doi.org/10.1172/jci70420
Joy NG, Mikeladze M, Younk LM, Tate DB, Davis SN (2016) Effects of equivalent sympathetic activation during hypoglycemia on endothelial function and pro-atherothrombotic balance in healthy individuals and obese standard treated type 2 diabetes. Metabolism 65(12):1695–1705. https://doi.org/10.1016/j.metabol.2016.09.001
Aschbacher K, Mills PJ, von Känel R, Hong S, Mausbach BT, Roepke SK, Dimsdale JE, Patterson TL, Ziegler MG, Ancoli-Israel S, Grant I (2008) Effects of depressive and anxious symptoms on norepinephrine and platelet P-selectin responses to acute psychological stress among elderly caregivers. Brain Behav Immun 22(4):493–502. https://doi.org/10.1016/j.bbi.2007.10.002
Almendros I, Carreras A, Ramírez J, Montserrat JM, Navajas D, Farré R (2008) Upper airway collapse and reopening induce inflammation in a sleep apnoea model. Eur Respir J 32(2):399–404. https://doi.org/10.1183/09031936.00161607
Nácher M, Serrano-Mollar A, Farré R, Panés J, Seguí J, Montserrat JM (2007) Recurrent obstructive apneas trigger early systemic inflammation in a rat model of sleep apnea. Respir Physiol Neurobiol 155(1):93–96. https://doi.org/10.1016/j.resp.2006.06.004
Jurado-Gámez B, Fernandez-Marin MC, Gómez-Chaparro JL, Muñoz-Cabrera L, Lopez-Barea J, Perez-Jimenez F, Lopez-Miranda J (2011) Relationship of oxidative stress and endothelial dysfunction in sleep apnoea. Eur Respir J 37(4):873–879. https://doi.org/10.1183/09031936.00027910
Jurado-Gamez B, Bujalance Cabrera C, Caballero Ballesteros L, Marin Hinojosa C, Muñoz Cabrera L, Perez-Jimenez F, Lopez-Miranda J (2012) Association of cellular adhesion molecules and oxidative stress with endothelial function in obstructive sleep apnea. Intern Med 51(4):363–368. https://doi.org/10.2169/internalmedicine.51.6571
Seljeflot I, Tonstad S, Hjermann I, Arnesen H (2002) Reduced expression of endothelial cell markers after 1 year treatment with simvastatin and atorvastatin in patients with coronary heart disease. Atherosclerosis 162(1):179–185. https://doi.org/10.1016/s0021-9150(01)00696-7
Özsavcı D, Şener A, Oba R, Yanıkkaya Demirel G, Uras F, Yardımcı TK (2010) New in vitro effects of clopidogrel on platelets in hyperlipidemic and healthy subjects. Turk j haematol 27(2):99–108. https://doi.org/10.5152/tjh.2010.07
Ferroni P, Martini F, Riondino S, La Farina F, Magnapera A, Ciatti F, Guadagni F (2009) Soluble P-selectin as a marker of in vivo platelet activation. Clin Chim Acta 399(1–2):88–91. https://doi.org/10.1016/j.cca.2008.09.018
Krieger AC, Anand R, Hernandez-Rosa E, Maidman A, Milrad S, DeGrazia MQ, Choi AJ, Oromendia C, Marcus AJ, Drosopoulos JHF (2020) Increased platelet activation in sleep apnea subjects with intermittent hypoxemia. Sleep Breath. https://doi.org/10.1007/s11325-020-02021-4
López-Cano C, Rius F, Sánchez E, Gaeta AM, Betriu À, Fernández E, Yeramian A, Hernández M, Bueno M, Gutiérrez-Carrasquilla L, Dalmases M, Lecube A (2019) The influence of sleep apnea syndrome and intermittent hypoxia in carotid adventitial vasa vasorum. PLoS ONE 14(2):e0211742. https://doi.org/10.1371/journal.pone.0211742
Harsch IA, Bergmann T, Koebnick C, Wiedmann R, Ruderich F, Hahn EG, Konturek PC (2007) Adiponectin, resistin and subclinical inflammation–the metabolic burden in Launois Bensaude Syndrome, a rare form of obesity. J physiol pharmacol 58(Suppl 1):65–76
Funding
No Funding was received.
Author information
Authors and Affiliations
Contributions
Conceptualization: DZ; literature search: ZX; formal analysis: DZ and ZX; writing—original draft preparation: DZ; writing—review and editing: YL; supervision: TL
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
No informed consent is needed for a systematic review.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhu, D., Xu, Z., Liu, T. et al. Soluble P-selectin levels in patients with obstructive sleep apnea: a systematic review and meta-analysis. Eur Arch Otorhinolaryngol 278, 4633–4644 (2021). https://doi.org/10.1007/s00405-021-06831-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-021-06831-4